Skip to content
★ Sign in to follow
RW

Robert W. Karr

Oncternal Therapeutics, Inc.Idera Pharmaceuticals, Inc.
Total declarations
24
Companies
2
▲ Purchases (1 ops.)
€7,587
▼ Sales (0 ops.)
—

Latest filing published 18 Sept 2013 for Idera Pharmaceuticals, INC., €7,587.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Robert W. Karr: trading record in brief

This profile gathers the share dealings of Robert W. Karr across 2 companies, led by Oncternal Therapeutics, Inc. and Idera Pharmaceuticals, Inc. We count 24 filings; the first trade dates from 1 January 2006 and the latest from 16 September 2013.

The open-market record is one-sided, with 1 purchase worth €7,587 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 23 share grants. So far in 2013, the count stands at 1 purchase and no sales.

The record was last updated on 18 September 2013 with an open-market purchase (€7,587) in Idera Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Robert W. Karr

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations